Trial Profile
Clinical Trials Insight: 700058098
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 28 Oct 2010
Price :
$35
*
At a glance
- Drugs Bambuterol (Primary)
- Indications Asthma
- Focus Adverse reactions
- 27 Oct 2010 Status changed from recruiting to not yet recruiting, according to a Lotus Pharmaceuticals media release.
- 27 Aug 2010 Status changed from not yet recruiting to recruiting, according to a Lotus Pharmaceuticals media release.
- 26 Aug 2010 According to a Lotus Pharmaceuticals media release, this phase I trial is now inn progress and on-track to be completed in six months.